AssessinG Efficacy of Carboplatin and ATezOlizumab in Metastatic Lobular Breast Cancer
Status:
Recruiting
Trial end date:
2029-07-01
Target enrollment:
Participant gender:
Summary
This is a single arm multicenter non-randomized phase II trial testing the efficacy of the
combination of carboplatin plus atezolizumab in metastatic ILC